Adheris Health Limited (ASX:AHE)
Australia · Delayed Price · Currency is AUD 0.0130
0.00 (0.00%)
Sep 8, 2026, 12:54 PM AEST
Adheris Health Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Operating Revenue | 33.96 | 62.99 | 98.4 | 97.96 | 67.75 |
| 33.96 | 62.99 | 98.4 | 97.96 | 67.75 | |
Revenue Growth | -46.09% | -35.98% | 0.45% | 44.59% | 74.74% |
Cost of Revenue | 36.77 | 59.02 | 78.61 | 81.18 | 71.15 |
Gross Profit | -2.81 | 3.97 | 19.79 | 16.78 | -3.4 |
Selling, General & Admin | 9.24 | 10.71 | 12.14 | 13.24 | 2.66 |
Other Operating Expenses | 3.96 | 3.13 | 4.57 | 5.22 | 5.24 |
Operating Expenses | 13.35 | 17.03 | 20.22 | 23.81 | 12.79 |
Operating Income | -16.16 | -13.06 | -0.43 | -7.03 | -16.19 |
Interest Expense | -3.7 | -2.87 | -1.93 | -2.13 | -1.54 |
Interest & Investment Income | 0.05 | 0.08 | 0.16 | 0.05 | 0 |
EBT Excluding Unusual Items | -19.81 | -15.85 | -2.21 | -9.11 | -17.73 |
Merger & Restructuring Charges | -0.53 | -0.92 | - | -1.4 | - |
Impairment of Goodwill | - | -35.19 | - | - | - |
Asset Writedown | - | -11.35 | - | - | - |
Pretax Income | -20.34 | -63.31 | -2.21 | -10.52 | -17.73 |
Income Tax Expense | -0.37 | 0.01 | 0.13 | 0.79 | -0.24 |
Earnings From Continuing Operations | -19.97 | -63.32 | -2.34 | -11.31 | -17.49 |
Earnings From Discontinued Operations | 15.66 | 3.11 | 3.13 | - | - |
Net Income to Company | -4.31 | -60.21 | 0.79 | -11.31 | -17.49 |
Minority Interest in Earnings | - | - | - | - | 0.14 |
Net Income | -4.31 | -60.21 | 0.79 | -11.31 | -17.35 |
Net Income to Common | -4.31 | -60.21 | 0.79 | -11.31 | -17.35 |
Net Income Growth | - | - | - | - | - |
Shares Outstanding (Basic) | 634 | 566 | 548 | 545 | 378 |
Shares Outstanding (Diluted) | 634 | 566 | 597 | 545 | 378 |
Shares Change | 12.10% | -5.29% | 9.57% | 44.12% | 19.47% |
EPS (Basic) | -0.01 | -0.11 | 0.00 | -0.02 | -0.05 |
EPS (Diluted) | -0.01 | -0.11 | 0.00 | -0.02 | -0.05 |
EPS Growth | - | - | - | - | - |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Free Cash Flow | -10.27 | -14.37 | 5.12 | -1.63 | -0.55 |
Free Cash Flow Per Share | -0.02 | -0.03 | 0.01 | -0.00 | -0.00 |
Gross Margin | -8.27% | 6.31% | 20.11% | 17.13% | -5.01% |
Operating Margin | -47.58% | -20.73% | -0.44% | -7.18% | -23.89% |
Profit Margin | -12.69% | -95.58% | 0.80% | -11.54% | -25.60% |
Free Cash Flow Margin | -30.24% | -22.80% | 5.21% | -1.67% | -0.81% |
EBITDA | -16.11 | -11.93 | 0.82 | -4.78 | -14.36 |
EBITDA Margin | -47.44% | -18.94% | 0.83% | -4.87% | -21.20% |
D&A For EBITDA | 0.05 | 1.12 | 1.25 | 2.26 | 1.83 |
EBIT | -16.16 | -13.06 | -0.43 | -7.03 | -16.19 |
EBIT Margin | -47.58% | -20.73% | -0.44% | -7.18% | -23.89% |